Exact Mass: 642.3208216
Exact Mass Matches: 642.3208216
Found 211 metabolites which its exact mass value is equals to given mass value 642.3208216,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Steviobioside
Steviolbioside is a beta-D-glucoside that is steviolmonoside in which the hydroxy group at position 2 of the glucoside moiety has been converted into its beta-D-glucoside. It has a role as a sweetening agent, a plant metabolite and an antitubercular agent. It is a beta-D-glucoside, an ent-kaurane diterpenoid, a monocarboxylic acid, a bridged compound, a diterpene glycoside and a tetracyclic diterpenoid. It is functionally related to a steviolmonoside. It is a conjugate acid of a steviolbioside(1-). Steviolbioside has been used in trials studying the treatment of HIV-1 Infection. Steviolbioside is a natural product found in Stevia rebaudiana with data available. See also: Stevia rebaudiuna Leaf (part of). Steviobioside belongs to the class of organic compounds known as steviol glycosides. These are prenol lipids containing a carbohydrate moiety glycosidically linked to a steviol (a diterpenoid based on a 13-hydroxykaur-16-en-18-oic acid) moiety. Steviobioside is an extremely weak basic (essentially neutral) compound (based on its pKa). Steviobioside is present in Stevia rebaudiana (stevia) extracts. A beta-D-glucoside that is steviolmonoside in which the hydroxy group at position 2 of the glucoside moiety has been converted into its beta-D-glucoside. D000074385 - Food Ingredients > D005503 - Food Additives D010592 - Pharmaceutic Aids > D005421 - Flavoring Agents Present in Stevia rebaudiana (stevia) extracts Steviolbioside is a rare sweetener that exists in stevia rebaudiana leaves. Steviolbioside presents inhibition on several human cancer cells and acts as potential remedy for human breast cancer[1]. Steviolbioside is a rare sweetener that exists in stevia rebaudiana leaves. Steviolbioside presents inhibition on several human cancer cells and acts as potential remedy for human breast cancer[1].
Bz-Pro-Phe-Arg-pNA
Benzoyl-prolyl-phenylalanyl-arginine-p-nitroanilide
Dihydrotestosterone diglucuronide
PA(10:0/PGJ2)
PA(10:0/PGJ2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/PGJ2), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of Prostaglandin J2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(PGJ2/10:0)
PA(PGJ2/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGJ2/10:0), in particular, consists of one chain of one Prostaglandin J2 at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
Rubusoside
Rubusoside is a steviol glycoside that is steviol in which both the carboxy group and the tertiary allylic hydroxy group have been converted to their corresponding beta-D-glucosides. A precious bioactive natural sweetener which mainly exists the in Chinese sweet tea plant, Rubus suavissimus. It has a role as a sweetening agent and a plant metabolite. It is a beta-D-glucoside, a tetracyclic diterpenoid, a bridged compound and a steviol glycoside. It is functionally related to a steviol. Rubusoside is a natural product found in Rubus chingii var. suavissimus with data available. A steviol glycoside that is steviol in which both the carboxy group and the tertiary allylic hydroxy group have been converted to their corresponding beta-D-glucosides. A precious bioactive natural sweetener which mainly exists the in Chinese sweet tea plant, Rubus suavissimus. [Chemical] Source; leaves of Stevia rebaudiana Morita and Stevia rebaudiana Bertoni Rubusoside is a natural sweetener and solubilizer with excellent anti-angiogenic and anti-allergic properties. Rubusoside is a diterpene glycoside that is also a sweetener and solubilizer with anti-angiogenic, anti-cancer, anti-obesity, anti-allergic and anti-asthmatic effects. Rubusoside attenuates airway hyperresponsiveness and reduces inflammatory cells in bronchoalveolar lavage fluid (BALF), reducing OVA (HY-W250978)-induced airway inflammation. Rubusoside also prevents palmitic acid-induced lipotoxicity in pancreatic INS-1 cells, reduces the transport of human glucose transporters GLUT-1 and fructose GLUT-5, and inhibits NF-κB and α-amylase (α-amylase)[1][2][3][4]. Rubusoside is a natural sweetener and solubilizer with excellent anti-angiogenic and anti-allergic properties.
Steviolbioside
D000074385 - Food Ingredients > D005503 - Food Additives D010592 - Pharmaceutic Aids > D005421 - Flavoring Agents [Chemical] Source; leaves of Stevia rebaudiana Morita and Stevia rebaudiana Bertoni Steviolbioside is a rare sweetener that exists in stevia rebaudiana leaves. Steviolbioside presents inhibition on several human cancer cells and acts as potential remedy for human breast cancer[1]. Steviolbioside is a rare sweetener that exists in stevia rebaudiana leaves. Steviolbioside presents inhibition on several human cancer cells and acts as potential remedy for human breast cancer[1].
Trichoverritone
(2R*,3S*,4S*,7S*,8S*,9S*,13S*,14S*,15R*)-8,9,14,15-tetraacetoxy-3-benzoyloxy-7-hydroxyjatropha-5E,11E-diene
20-hydroxy-beta-ecdysone-3-O-beta-D-glucopyranoside|20-hydroxyecdysone 3-beta-D-glucopyranoside|20-hydroxyecdysone 3-O-beta-D-glucoside|20-Hydroxyecdysone-3-beta-D-glucopyranoside|Ecdysterone-3-O-??-D-glucopyranoside
17-[2,3-dihydroxy-6-methyl-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
(ent-15alpha)-O-beta-D-Glucopyranoside, beta-D-Glucopyranosyl ester-15-Hydroxy-16-kauren-19-oic acid
(24S,25R)-5alpha-Spirostan-2alpha,3beta,5alpha,6beta,24-pentaol 24-O-beta-D-glucopyranoside
(3beta,20S)-pregn-5-ene-3,20-diol 20-[O-beta-glucopyranosyl-(1->6)-O-beta-glucopyranoside]
aeruginosin DA642A|L-o-Cl-Hpla-L-Phe-L-Choi-agmatine
C32H43ClN6O6 (642.2932448000001)
3beta-benzoyloxy-15beta-hydroxy-7beta,8beta,9alpha,14beta-tetracetoxy-2alphaH,13alphaH-jatropha-5E,11E-diene|euphomelliferene B
2alpha,15-dihydroxy-3beta-(2?-hydroxy-2?-methyl-3?-acetoxy)butanoyloxy-6alpha,18-diacetoxy-4alpha,17-epoxyclerodan-11,16-lactone
12-deacetyloxy-12-isobutanoyloxyturrapubin A|turrapubin B
(16S,19E)-2-(18E)-alstophyll-18-en-18-yl-(2alpha,7alpha)-2,7-dihydro-1,16-cyclo-coryn-19-en-17-oic acid methyl ester|macrocarpamine
(3beta,20S)-pregn-5-ene-3,20-diol 3-beta-glucopyranoside 20-beta-glucopyranoside|3-O-beta-D-glucopyranosyl-(3beta,20S)-pregn-5-ene-3,20-diol 20-O-beta-D-glucopyranoside|periseoside C
3-(6,7-dihydroxy-3,7-dimethyloct-1-enyl)-(3-alpha-L-rhamnopyranosyl)-(4-O-cis-p-coumaroyl)-beta-D-glucopyranoside|lipedoside B-V
Euphorbia Factor L2
Euphorbia Factor L2 is a natural product found in Euphorbia lathyris with data available. Euphorbia factor L2, a lathyrane diterpenoid isolated from caper euphorbia seed (the seeds of Euphorbia lathyris L.), has been traditionally applied to treat cancer. Euphorbia factor L2 shows potent cytotoxicity and induces apoptosis via a mitochondrial pathway[1]. Euphorbia factor L2, a lathyrane diterpenoid isolated from caper euphorbia seed (the seeds of Euphorbia lathyris L.), has been traditionally applied to treat cancer. Euphorbia factor L2 shows potent cytotoxicity and induces apoptosis via a mitochondrial pathway[1].
5,7-diacetoxy-3-benzoyloxy-14,15-dihydroxy-8-isobutyryloxy-9-oxojatropha-6(17),11E-diene (9)
C35H46O11_3aH-Cyclopentacyclododecene-1,3a,4,9,10,11-hexol, 1,2,3,4,5,8,9,10,11,13a-decahydro-2,5,8,8,12-pentamethyl-, 3a,4,9,10-tetraacetate 1-benzoate, (6E,12Z)
Steviobioside
D000074385 - Food Ingredients > D005503 - Food Additives D010592 - Pharmaceutic Aids > D005421 - Flavoring Agents Origin: Plant; SubCategory_DNP: Diterpenoids, Kaurane diterpenoids, Steviolbioside diterpenoids Steviolbioside is a rare sweetener that exists in stevia rebaudiana leaves. Steviolbioside presents inhibition on several human cancer cells and acts as potential remedy for human breast cancer[1]. Steviolbioside is a rare sweetener that exists in stevia rebaudiana leaves. Steviolbioside presents inhibition on several human cancer cells and acts as potential remedy for human breast cancer[1].
17-[2,3-dihydroxy-6-methyl-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one [IIN-based: Match]
Phe Lys Trp Tyr
Phe Lys Tyr Trp
Phe Gln Trp Tyr
Phe Gln Tyr Trp
Phe Trp Lys Tyr
Phe Trp Gln Tyr
Phe Trp Tyr Lys
Phe Trp Tyr Gln
Phe Tyr Lys Trp
Phe Tyr Gln Trp
Phe Tyr Trp Lys
Phe Tyr Trp Gln
Lys Phe Trp Tyr
Lys Phe Tyr Trp
Lys Trp Phe Tyr
Lys Trp Tyr Phe
Lys Tyr Phe Trp
Lys Tyr Trp Phe
Gln Phe Trp Tyr
Gln Phe Tyr Trp
Gln Trp Phe Tyr
Gln Trp Tyr Phe
Gln Tyr Phe Trp
Gln Tyr Trp Phe
Trp Phe Lys Tyr
Trp Phe Gln Tyr
Trp Phe Tyr Lys
Trp Phe Tyr Gln
Trp Lys Phe Tyr
Trp Lys Tyr Phe
Trp Gln Phe Tyr
Trp Gln Tyr Phe
Trp Tyr Phe Lys
Trp Tyr Phe Gln
Trp Tyr Lys Phe
Trp Tyr Gln Phe
Tyr Phe Lys Trp
Tyr Phe Gln Trp
Tyr Phe Trp Lys
Tyr Phe Trp Gln
Tyr Lys Phe Trp
Tyr Lys Trp Phe
Tyr Gln Phe Trp
Tyr Gln Trp Phe
Tyr Trp Phe Lys
Tyr Trp Phe Gln
Tyr Trp Lys Phe
Tyr Trp Gln Phe
Phenol, 2,6-bis[[bis(2-pyridinylmethyl)amino]Methyl]-4-(2-naphthalenyl)-
Urea, N-(2-methoxy-5-methylphenyl)-N-(6-((6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-4-quinazolinyl)amino)-2-benzothiazolyl)-
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
N,N-[2,5-O-[Dibenzyl]-glucaryl]-DI-[isoleucyl-amido-methane]
C34H50N4O8 (642.3628460000001)
17-[2,3-dihydroxy-6-methyl-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
3-oxo-5alpha-androstan-17beta-yl 2-O-beta-D-glucopyranuronosyl-beta-D-glucopyranosiduronic acid
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
2,3,16-Triacetate-15-oxo-23,24-dihydroxycucurbitacin
Dihydrotestosterone diglucuronide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
2-[[(2R)-3-acetyloxy-2-[(5Z,7R,8E,10Z,13Z,15E,17S,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[(4Z,7Z,10R,11E,13Z,15E,17S,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
12beta-Acetoxyhuratoxin
A natural product found in Pimelea elongata and Pimelea simplex.
Gln-Phe-Trp-Tyr
A tetrapeptide composed of L-glutamine, L-phenylalanine, L-tryptophan and L-tyrosine joined in sequence by peptide linkages.
[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
[3-Acetyloxy-16-(furan-3-yl)-2,7,7,11,17-pentamethyl-10-(2-methylpropanoyloxy)-5-oxo-6,13-dioxapentacyclo[9.8.0.02,8.012,14.012,17]nonadecan-18-yl] 2-methylpropanoate
[1-Heptanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] tridecanoate
C29H55O13P (642.3380109999999)
[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-octanoyloxypropan-2-yl] dodecanoate
C29H55O13P (642.3380109999999)
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate
[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] heptadecanoate
C29H55O13P (642.3380109999999)
[1-Butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] hexadecanoate
C29H55O13P (642.3380109999999)
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
[1-Hexanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] tetradecanoate
C29H55O13P (642.3380109999999)
[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] pentadecanoate
C29H55O13P (642.3380109999999)
[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-nonanoyloxypropan-2-yl] undecanoate
C29H55O13P (642.3380109999999)
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
[2-Decanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] decanoate
C29H55O13P (642.3380109999999)
[1-Acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] octadecanoate
C29H55O13P (642.3380109999999)
1-2-Di-decanoyl-sn-glycero-3-phosphoinositol
C29H55O13P (642.3380109999999)